SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010938
Filing Date
2024-03-22
Accepted
2024-03-22 12:46:01
Documents
61
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1393649
2 ex4-4.htm EX-4.4 7616
3 ex31-1.htm EX-31.1 17761
4 ex31-2.htm EX-31.2 10839
5 ex32-1.htm EX-32.1 4224
6 ex32-2.htm EX-32.2 4258
7 ex97-1.htm EX-97.1 77897
  Complete submission text file 0001493152-24-010938.txt   5054636

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE acut-20231231.xsd EX-101.SCH 27599
9 XBRL CALCULATION FILE acut-20231231_cal.xml EX-101.CAL 42561
10 XBRL DEFINITION FILE acut-20231231_def.xml EX-101.DEF 121073
11 XBRL LABEL FILE acut-20231231_lab.xml EX-101.LAB 289120
12 XBRL PRESENTATION FILE acut-20231231_pre.xml EX-101.PRE 222790
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 584648
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56257 | Film No.: 24774441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)